Cauvin C, Hwang O, Yamamoto M, van Breemen C
Am J Cardiol. 1987 Jan 30;59(3):116B-122B. doi: 10.1016/0002-9149(87)90090-7.
Contractile tension responses to norepinephrine and depolarizing potassium (80 mM K+), as well as calcium-45 influx stimulated by these agents, were studied in isolated mesenteric resistance vessels (each 100 microM internal diameter) from spontaneously hypertensive rats (SHRs) and from normotensive Wistar Kyoto rats (WKYs). Inhibitory effects of 2 dihydropyridine Ca++ antagonists, PN 200-110 (isradipine) and nisoldipine, on these parameters were also determined. Contractile responses to 80 mM K+ were inhibited by both Ca++ antagonists with the same potency and efficacy in SHR compared with WKY vessels (PN 200-110 IC50 = 2.8 +/- 1.3 X 10(-8) M in SHRs and 2.5 +/- 1.5 X 10(-8) M in WKYs; nisoldipine IC50 = 1.1 +/- 0.4 X 10(-8) M in SHRs and 1.2 +/- 0.9 X 10(-8) M in WKYs). However, contractile responses to norepinephrine (10(-4) M) were inhibited less potently by nisoldipine in SHR vessels (IC50 = 2.2 +/- 0.3 X 10(-9) M) compared with WKY vessels (IC50 = 1.6 +/- 0.6 X 10(-10) M). Similarly, PN 200-110 tended to be less (but not significantly less) potent in SHR vessels (IC50 = 3.3 +/- 1.8 X 10(-8) M) than in WKY vessels (IC50 = 3.4 +/- 0.9 X 10(-9) M); its efficacy was significantly depressed in the SHR vessels (by approximately 20%). When norepinephrine-stimulated calcium-45 influx was determined in the presence of these Ca++ antagonists, a similar profile emerged with respect to a comparison of SHR and WKY vessels. These results support a previously hypothesized alteration in receptor-activated Ca++ influx pathways in SHR mesenteric resistance vessels.
在来自自发性高血压大鼠(SHR)和正常血压的Wistar Kyoto大鼠(WKY)的离体肠系膜阻力血管(内径均为100微米)中,研究了对去甲肾上腺素和去极化钾(80 mM K+)的收缩张力反应,以及这些药物刺激的钙-45内流。还测定了2种二氢吡啶类钙离子拮抗剂PN 200-110(伊拉地平)和尼索地平对这些参数的抑制作用。与WKY血管相比,两种钙离子拮抗剂对SHR血管中80 mM K+引起的收缩反应的抑制效力和效果相同(PN 200-110在SHR中的IC50 = 2.8 +/- 1.3×10^(-8) M,在WKY中为2.5 +/- 1.5×10^(-8) M;尼索地平在SHR中的IC50 = 1.1 +/- 0.4×10^(-8) M,在WKY中为1.2 +/- 0.9×10^(-8) M)。然而,与WKY血管(IC50 = 1.6 +/- 0.6×10^(-10) M)相比,尼索地平对SHR血管中去甲肾上腺素(10^(-4) M)引起的收缩反应的抑制效力较弱(IC50 = 2.2 +/- 0.3×10^(-9) M)。同样,PN 200-110对SHR血管(IC50 = 3.3 +/- 1.8×10^(-8) M)的效力往往低于WKY血管(IC50 = 3.4 +/- 0.9×10^(-9) M),但差异不显著;其效果在SHR血管中显著降低(约20%)。当在这些钙离子拮抗剂存在的情况下测定去甲肾上腺素刺激的钙-45内流时,在比较SHR和WKY血管方面出现了类似的情况。这些结果支持了先前假设的SHR肠系膜阻力血管中受体激活的钙内流途径的改变。